Christian Baumann

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Integration of Auditory, and Deep Brain Stimulation to Enhance Deep Sleep in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Device: Acoustic stimulation

First Posted Date: 2022-01-11

Last Posted Date: 2023-09-21

Lead Sponsor: Christian Baumann

Target Recruit Count: 15

Registration Number: NCT05184270

Locations: 🇨🇭
Department of Neurology, University Hospital Zurich, Zurich, Switzerland

Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease

Not Applicable

Conditions: Parkinson Disease
Huntington Disease
Mild Cognitive Impairment

Interventions: Device: MHSL- SleepBand
Device: Sham

First Posted Date: 2020-10-19

Last Posted Date: 2021-07-06

Lead Sponsor: Christian Baumann

Target Recruit Count: 12

Registration Number: NCT04589182

Locations: 🇨🇭
University Hospital Zurich, Neurology department, Zürich, Zurich, Switzerland

Decision-making After Sleep Restriction

Not Applicable

Completed

Conditions: Sleep Restriction

Interventions: Behavioral: Sleep restriction
Other: Acoustic stimulation

First Posted Date: 2018-10-02

Last Posted Date: 2021-02-11

Lead Sponsor: Christian Baumann

Target Recruit Count: 28

Registration Number: NCT03692962

Locations: 🇨🇭
University Hospital Zurich, Zürich, Zurich, Switzerland

Acoustic Cueing During Slow-wave Sleep as a Measure to Improve Motor Rehabilitation Outcome in Stroke Patients

Not Applicable

Conditions: Stroke

Interventions: Behavioral: melody only during motor training
Behavioral: melody during motor training and slow wave sleep

First Posted Date: 2018-09-25

Last Posted Date: 2020-11-20

Lead Sponsor: Christian Baumann

Target Recruit Count: 12

Registration Number: NCT03684603

Locations: 🇨🇭
University Hospital Zurich, Zurich, Switzerland

Cortical Excitability and Decision Making After Total Sleep Deprivation and Sleep Restriction

Not Applicable

Completed

Conditions: Acute and Partial Sleep Deprivation

Interventions: Behavioral: Sleep Deprivation

First Posted Date: 2014-12-02

Last Posted Date: 2020-11-20

Lead Sponsor: Christian Baumann

Target Recruit Count: 14

Registration Number: NCT02305225

Locations: 🇨🇭
University Hospital Zurich, Division of Neurology, Zurich, ZH, Switzerland

Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease

Phase 2

Completed

Conditions: Sleep-wake Disturbances in Motor-phase Parkinson's Disease

Interventions: Drug: Placebo
Drug: Sodium Oxybate

First Posted Date: 2014-04-10

Last Posted Date: 2021-01-25

Lead Sponsor: Christian Baumann

Target Recruit Count: 16

Registration Number: NCT02111122

Locations: 🇨🇭
Department of Neurology, Zurich, Switzerland

Inhibiting COMT in Parkinson's Disease

Withdrawn

Conditions: Parkinson's Disease

First Posted Date: 2014-02-25

Last Posted Date: 2021-01-25

Lead Sponsor: Christian Baumann

Registration Number: NCT02070887

Locations: 🇨🇭
University Hospital Zurich, Division of Neurology, Zurich, ZH, Switzerland

Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment

Phase 2

Completed

Conditions: Autonomic Disturbances in Parkinson's Disease

Interventions: Drug: fludrocortisone
Drug: Pyridostigmine bromide

First Posted Date: 2013-11-25

Last Posted Date: 2021-01-25

Lead Sponsor: Christian Baumann

Target Recruit Count: 18

Registration Number: NCT01993680

Locations: 🇨🇭
University Hospital Zurich, Division of Neurology, Zurich, ZH, Switzerland

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy